Income Statement
TENAYA THERAPEUTICS, INC.
TNYA
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - |
|
Operating Expenses
|
93.33 | 115.95 | 131.19 | 125.62 | 72.81 |
|
Research & Development
|
68.61 | 86.74 | 98.04 | 94.54 | 54.39 |
|
Selling, General & Administrative
|
24.72 | 29.21 | 33.16 | 31.08 | 18.41 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-93.33 | -115.95 | -131.19 | -125.62 | -72.81 |
|
Non-Operating Income
|
2.73 | 4.82 | 7.11 | 1.96 | 0.09 |
|
Interest Income
|
2.68 | 4.74 | 7.06 | 1.95 | 0.11 |
|
Interest Expense
|
- | - | - | - | - |
|
Other Non-Op Income / Expense
|
0.05 | 0.08 | 0.05 | 0.00 | -0.02 |
|
Income Before Tax
|
-90.60 | -111.13 | -124.08 | -123.67 | -72.72 |
|
Income Tax Expense
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-90.60 | -111.13 | -124.08 | -123.67 | -72.72 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-84.90 | -107.48 | -122.51 | -119.15 | -69.85 |
|
Earnings Per Share (Basic)
|
-0.59 | -1.31 | -1.68 | -2.76 | - |
|
Diluted EPS
|
-0.59 | -1.31 | -1.68 | -2.76 | - |
|
Weighted Average Shares
|
152.97 | 84.82 | 73.79 | 44.82 | - |
|
Diluted Weighted Avg Shares
|
152.97 | 84.82 | 73.79 | 44.82 | - |
|
Comprehensive Income
|
-90.63 | -111.00 | -123.81 | -123.90 | -72.86 |